Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors

Overview of attention for article published in Frontiers in oncology, February 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 1 news outlet

twitter: 3 X users

Readers on

mendeley: 13 Mendeley

Summary News X

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 26,035 followers.

Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors https://t.co/oTsGA0ICje

03 Mar 2023

Reply Repost Favourite

Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors https://t.co/HId9otEGSl

03 Mar 2023

Reply Repost Favourite

Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors https://t.co/aCUjtoLGAt https://t.co/gpGgkYKm33

16 Feb 2023

Reply Repost Favourite

New research: Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors: Background In patients with cirrhosis, portal hypertension increases intestinal permeability, dysbiosis, and bacterial… https://t.co

15 Feb 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.